Science 14Feb2020

(Wang) #1

Join us to shape


thefutureof


Oncology


At GSK, we are striving to maximize patient


survival through transformational medicines


for people living with cancer. Our unique R&D


approach seeks to discover new approaches to


fighting cancer on multiple groundbreaking fronts:



  • Immuno-Oncology:using the human immune


system to treat cancer



  • Cell/Gene Therapy:engineering human T-cells


to target cancer



  • Cancer Epigenetics:modulating the gene-


regulatory system of the epigenome to exert
anti-cancer effects


  • Synthetic Lethality:targeting two mechanisms


at the same time which together, but not alone,
have substantial effects against cancer

Through investing in scientific and technical
excellence in these areas, our goal is to develop
new therapies for patients living with cancer with
unmet medical needs.

Weareactivelyrecruitingkeytalent


forpositionswithinourSynthetic


Lethality platform in our Boston


and Philadelphia locations.


Join us.


GSKOncologyCareers.com

Free download pdf